LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 267 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $231,000 | -1.3% | 2,184 | -5.1% | 0.03% | +7.7% |
| Q4 2016 | $234,000 | -31.4% | 2,302 | -31.0% | 0.03% | -16.1% |
| Q3 2016 | $341,000 | -36.0% | 3,338 | -25.3% | 0.03% | -35.4% |
| Q2 2016 | $533,000 | -39.8% | 4,471 | -46.0% | 0.05% | -35.1% |
| Q1 2016 | $886,000 | -43.2% | 8,278 | -42.5% | 0.07% | -35.1% |
| Q4 2015 | $1,561,000 | -69.5% | 14,399 | -75.9% | 0.11% | -40.0% |
| Q3 2015 | $5,126,000 | – | 59,858 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |